{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:03:55Z","timestamp":1791443035014,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["19TPA34880016"],"award-info":[{"award-number":["19TPA34880016"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["P01-HL139420"],"award-info":[{"award-number":["P01-HL139420"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["P01-HL146373"],"award-info":[{"award-number":["P01-HL146373"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtha.2023.12.017","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T03:29:06Z","timestamp":1703302146000},"page":"1016-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function"],"prefix":"10.1016","volume":"22","author":[{"given":"Christopher D.","family":"Mansi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna R.","family":"Severa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya T.","family":"Marar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Stalker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.12.017_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","volume":"17","author":"Capodanno","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtha.2023.12.017_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1055\/s-0040-1713376","article-title":"Dual pathway inhibition for vascular protection in patients with atherosclerotic disease: rationale and review of the evidence","volume":"120","author":"Weitz","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.017_bib3","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.017_bib4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.017_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"ATLAS ACS 2\u2013TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.017_bib6","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.1161\/CIR.0000000000000507","volume":"135","author":"Cook","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.12.017_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/bloodadvances.2020003628","article-title":"A\u00a0systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms","volume":"5","author":"Hamuly\u00e1k","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.12.017_bib8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jacc.2022.01.011","article-title":"Left ventricular thrombus following acute myocardial infarction: JACC state-of-the-art review","volume":"79","author":"Camaj","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2023.12.017_bib9","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.017_bib10","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/bloodadvances.2017009498","article-title":"Coordination of platelet agonist signaling during the hemostatic response in\u00a0vivo","volume":"1","author":"Shen","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.12.017_bib11","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1073\/pnas.1813642116","article-title":"Interrelationships between structure and function during the hemostatic response to injury","volume":"116","author":"Tomaiuolo","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.12.017_bib12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI30537","article-title":"Thrombin-initiated platelet activation in\u00a0vivo is vWF independent during thrombus formation in a laser injury model","volume":"117","author":"Dubois","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.12.017_bib13","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood-2005-09-3687","article-title":"Glycoprotein VI-dependent and -independent pathways of thrombus formation in\u00a0vivo","volume":"107","author":"Dubois","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.017_bib14","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2012-09-457739","article-title":"Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network","volume":"121","author":"Stalker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.017_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nm.4149","article-title":"A\u00a0rapid pro-hemostatic approach to overcome direct oral anticoagulants","volume":"22","author":"Thalji","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2023.12.017_bib16","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood.2021014338","article-title":"Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis","volume":"139","author":"Marar","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.017_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2017.09.011","article-title":"Optimizing the presentation of bleeding and thrombosis data: Responding to censored data using Kaplan-Meier curves","volume":"158","author":"Bouck","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.12.017_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtha.2023.12.017_bib19","author":"Kane"},{"key":"10.1016\/j.jtha.2023.12.017_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.017_bib21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A\u00a0dual thrombin receptor system for platelet activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.12.017_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1073\/pnas.0610188104","article-title":"Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis","volume":"104","author":"Vandendries","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.12.017_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jth.15569","article-title":"Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability","volume":"20","author":"Lee","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.017_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jth.12802","article-title":"Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition","volume":"13","author":"Getz","year":"2015","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T10:08:05Z","timestamp":1744452485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623009157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1538783623009157"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.017","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}